Proactive news headlines: Amryt Pharma, Frontier IP Group, Xpediator…

0
9

Mineral and Financial Investments’ Lagoa Salada project in Portugal is worth US$361mln according to an independent pre-feasibility study, but the project is “still in its infancy from a geological understanding perspective”.


Amryt Pharma has raised its full-year 2021 revenue guidance due to a strong performance from recent acquisition of Chiasma and its own commercial products.


Bango PLC has announced the name of the “Tier 1” North American telecommunications company it recently signed a deal with.


Frontier IP Group PLC saw its shares rise 19.9% in early deals as it noted plans by one of its portfolio companies, Exscientia, to float in the US.


Caerus Mineral Resources PLC has released results from due diligence scout drilling on the recently acquired Pano Lefkara licence located in the Republic of Cyprus.


AdEPT Technology Group PLC said the recently acquired cloud networking and communications specialist Datrix is integrating well and achieving early key goals, including customer renewals and new business.


Bezant Resources PLC has entered into a conditional agreement with IDM Mankayan Pty Ltd, a company incorporated in Australia, to take the Mankayan project in the Philippines forward.


Xpediator Plc said revenues and profits for the full year will top expectations after a strong first half.


Salt Lake Potash Ltd has appointed highly experienced mining executive Isak Buitendag as new CEO as it moves to progress its flagship Lake Way Sulphate of Potash (SOP) Project in Western Australia.


Redx Pharma plc will present data from its RXC004 Phase 1 monotherapy study at the European Society for Medical Oncology Congress, held on 16-21 September.


Oriole Resources PLC said a phase 2 diamond drilling programme will soon begin at its 90%-owned Bibemi gold project in Cameroon.


Power Metal Resources PLC said it is getting increasingly optimistic about the Wallal Project in the Paterson region of Western Australia.

LEAVE A REPLY

Please enter your comment!
Please enter your name here